Plasmid DNA Manufacturing Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2021 - 2027

The global plasmid DNA manufacturing market is projected to grow at a CAGR of more than 21% over forecast period 2020 to 2027 and to reach the market value of around US$ 320 Mn by 2027.

The report provides size (in terms of volume and value) of Plasmid DNA manufacturing market for the base year 2020 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market. 

This report focuses on the global Plasmid DNA manufacturing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plasmid DNA manufacturing market development in United States, Europe and China.

Increasing Number of Patients Opting for Gene Therapy

Plasmid (pDNA) DNA plays a major role in modern healthcare, as it is used directly as a therapeutic agent in gene therapy or generation of vaccine antigens. Furthermore, pDNA is used as a master-template product to support production of new and emerging biopharmaceutical products and processes including RNA, in-vitro protein production, and cell therapies.

Increasing number of patients opting for gene therapy is expected to propel growth of plasmid DNA manufacturing market

Increasing number of patients opting for gene therapy is a major factor driving growth of the plasmid DNA manufacturing market. Gene therapy is a leading field in medical science, which promises new treatment development for patients suffering from various diseases.

For instance, Adeno-associated AAV2 vectors carrying therapeutic gene (RPE65) intra-retinal injection leads to improved vision of individuals suffering from Leber’s Congenital Amaurosis.

Several clinical trials are being conducted on viral vectors and plasmid DNA manufacturing that are focused on the potential of gene therapy. Increasing investments in drug development and commercialization of these therapies in order to meet significant medical needs are factors driving the market growth. These genetic markers are associated with complex diseases, therefore it is important to study about the genetic information and its clinical application in designing clinical trials and gene therapy product manufacturing.

Some of the key players operating in the report are Akron Biotech, Cobra Biologics Limited, VGXI, Inc., Aldevron, PlasmidFactory GmbH & Co. KG, LakePharma, Inc., Delphi Genetics, Waisman Biomanufacturing, Richter-Helm BioLogics, Eurogentec, Kaneka Corporation, Nature Technology Corporation, and Cell and Gene Therapy Catapult.

Segment Insights

Gene therapy accounts for the largest share of global plasmid DNA manufacturing market.

The market in North America is expected to contribute major revenue share in the global plasmid DNA manufacturing market. The market for plasmid DNA manufacturing in North America is driven by rapid technological advancements and R&D activities in the healthcare sector. In addition, presence of several biopharmaceutical manufacturers in the US coupled with a strong and effective regulatory structure for development of advanced therapies in the country is boosting the growth of this market in North America. Besides this, recent approval of gene therapies by US FDA is projected to augment the demand for plasmid DNA manufacturing in coming years.

The market in Asia Pacific is expected to witness faster growth in the global plasmid DNA manufacturing market. This can be attributed to the increasing government expenditure on development of healthcare infrastructure in the region. In addition, the growing government initiatives and increased investments by private companies related to R&D activities are likely to fuel this regional market.

Europe is expected to witness substantial growth in the market for plasmid DNA manufacturing. Factors that are expected to drive the growth in European market are significant incentives offered through Orphan Medicinal Products Regulations (European Union) that has encouraged pharmaceutical and biotechnology companies to consider the development of rare disease medicines as a potentially profitable endeavor.

Market Segmentation

By Application

  • Gene Therapy
  • Vaccinology

By Disease

  • Infectious Disease
  • Cancer
  • Genetic Disorder

By End use

  • Research Institute
  • Biotech Companies

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of LA
  • Middle East & Africa
    • Saudi
    • UAE
    • Rest of MEA

Overview

The Plasmid DNA manufacturing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Plasmid DNA manufacturing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Plasmid DNA manufacturing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Plasmid DNA manufacturing by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Plasmid DNA manufacturing market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Plasmid DNA manufacturing market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Plasmid DNA manufacturing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Plasmid DNA manufacturing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Plasmid DNA manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Plasmid DNA manufacturing market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Plasmid DNA manufacturing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Plasmid DNA manufacturing market. These factors have benefited the growth of the global market for Plasmid DNA manufacturing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Plasmid DNA manufacturing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Plasmid DNA manufacturing are as follows:

  • History Year: 2017-2020
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Year 2021 to 2027

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2027);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Plasmid DNA Manufacturing Market, By Disease

7.1. Plasmid DNA Manufacturing Market, by Disease Type, 2020-2027

7.1.1. Infectious Disease

7.1.1.1. Market Revenue and Forecast (2016-2027)

7.1.2. Cancer

7.1.2.1. Market Revenue and Forecast (2016-2027)

7.1.3. Genetic Disorder

7.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Plasmid DNA Manufacturing Market, By Application

8.1. Plasmid DNA Manufacturing Market, by Application, 2020-2027

8.1.1. Gene Therapy

8.1.1.1. Market Revenue and Forecast (2016-2027)

8.1.2. Vaccinology

8.1.2.1. Market Revenue and Forecast (2016-2027)

 

Chapter 9. Global Plasmid DNA Manufacturing Market, By End use 

 

9.1. Plasmid DNA Manufacturing Market, by End use, 2020-2027

9.1.1. Research Institute

9.1.1.1. Market Revenue and Forecast (2016-2027)

9.1.2. Biotech Companies

9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Plasmid DNA Manufacturing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Disease (2016-2027)

10.1.2. Market Revenue and Forecast, by Application (2016-2027)

10.1.3. Market Revenue and Forecast, by End use (2016-2027)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.1.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.1.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.6.3. Market Revenue and Forecast, by End use (2016-2027)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Disease (2016-2027)

10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)

10.2.7.3. Market Revenue and Forecast, by End use (2016-2027)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.6.3. Market Revenue and Forecast, by End use (2016-2027)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Disease (2016-2027)

10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)

10.3.7.3. Market Revenue and Forecast, by End use (2016-2027)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.6.3. Market Revenue and Forecast, by End use (2016-2027)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Disease (2016-2027)

10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)

10.4.7.3. Market Revenue and Forecast, by End use (2016-2027)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.5.3. Market Revenue and Forecast, by End use (2016-2027)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Disease (2016-2027)

10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)

10.5.4.3. Market Revenue and Forecast, by End use (2016-2027)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Disease (2016-2027)

10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)

10.5.5.3. Market Revenue and Forecast, by End use (2016-2027)

Chapter 11. Company Profiles

11.1. Akron Biotech

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Cobra Biologics Limited

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. VGXI, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Aldevron

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. PlasmidFactory GmbH & Co. KG

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. LakePharma, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Delphi Genetics

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Waisman Biomanufacturing

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Richter-Helm BioLogics

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Eurogentec

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers